Breath biopsy device developer Owlstone Medical recently announced the appointment of Neil Tween as its new CFO.
Tween joins Owlstone from GW Pharmaceuticals, a publicly listed pharmaceutical company where he served as VP and group financial controller, according to a March 30 news release from the company.
Read the full story on our WTWH Media sister site R&D World.